RSNA 2010 

Abstract Archives of the RSNA, 2010


VI21-09

Treatment of Symptomatic High-Flow Female Varicocele with Balloon-occluded Retrograde Transvenous Foam Sclerotherapy (B-ORTFS) Using Sodium-tetradecyl-sulphate Foam

Scientific Formal (Paper) Presentations

Presented on November 29, 2010
Presented as part of VI21: Interventional Radiology Series: Interventions in the Female Pelvis

Participants

Roberto Gandini MD, Abstract Co-Author: Nothing to Disclose
Daniel Konda, Presenter: Nothing to Disclose
Marcello Chiocchi MD, Abstract Co-Author: Nothing to Disclose
Eleonora Gaspari, Abstract Co-Author: Nothing to Disclose
Luca Boi MD, Abstract Co-Author: Nothing to Disclose
Giovanni Simonetti MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To assess the efficacy of Balloon-Occluded Retrograde Transvenous Foam Sclerotherapy (B-ORTFS) in high-flow pelvic varicocele using 3% sodium-tetradecyl-sulphate (STS) foam.

METHOD AND MATERIALS

A retrospective study was conducted in 12 patients (mean age: 35.2 years; range: 23-46) with pelvic congestion syndrome (PCS) with atypical high-flow venous collaterals treated by B-ORTFS between June 2005 and May 2008 at our Department. Full approval and waiver of informed consent for our study was obtained by our institutional review board. PCS was diagnosed by physical and transvaginal color-Doppler US examination, while high-flow venous collaterals were detected at selective ovarian venography. B-ORTFD was performed by injection of 3% STS foam into the pelvic varices after balloon-occlusion of the major venous vessels (hypogastric or ovarian veins) to which the high-flow venous collaterals were tributary. Follow-up was performed at 1, 3, 6 and 12 months by physical and transvaginal color-Doppler US examination and by a questionnaire-based assessment of pain using a Symptom Severity Score (SSS).

RESULTS

The procedure was technical successful in all patients (100%). After the injection of 3% STS foam, 3 (25.0%) patients presented a colic-like pain with spontaneous resolution after 5 minutes. During follow-up, no recurrences of PCS were detected. A significant improvement of symptoms (Student’s t test P<0.01) was observed at 1, 3, 6 and 12 months.

CONCLUSION

B-ORTFS of high-flow female varicocele using 3% STS foam is a safe and effective procedure that should be taken into consideration as an alternative to other endovascular and surgical options.

CLINICAL RELEVANCE/APPLICATION

Treatment of PCS with high-flow venous collaterals by B-ORTFS is a safe and effective alternative to conventional surgical techniques that is associated to lower complication rates.

Cite This Abstract

Gandini, R, Konda, D, Chiocchi, M, Gaspari, E, Boi, L, Simonetti, G, Treatment of Symptomatic High-Flow Female Varicocele with Balloon-occluded Retrograde Transvenous Foam Sclerotherapy (B-ORTFS) Using Sodium-tetradecyl-sulphate Foam.  Radiological Society of North America 2010 Scientific Assembly and Annual Meeting, November 28 - December 3, 2010 ,Chicago IL. http://archive.rsna.org/2010/9008939.html